| 1 |
34492683 | Modeling IKZF1 lesions in B-ALL reveals distinct chemosensitivity patterns and potential therapeutic vulnerabilities. | 2021 Oct 12 |
1 |
| 2 |
28052520 | IKAROS expression in distinct bone marrow cell populations as a candidate biomarker for outcome with lenalidomide-dexamethasone therapy in multiple myeloma. | 2017 Mar |
1 |
| 3 |
28529312 | Prognostic impact of IKZF1 deletions in association with vincristine-dexamethasone pulses during maintenance treatment of childhood acute lymphoblastic leukemia on trial ALL-BFM 95. | 2017 Aug |
1 |
| 4 |
24914135 | Identification of cereblon-binding proteins and relationship with response and survival after IMiDs in multiple myeloma. | 2014 Jul 24 |
1 |
| 5 |
20445578 | IKZF1 deletions predict relapse in uniformly treated pediatric precursor B-ALL. | 2010 Jul |
1 |